pfizer glp 1 weight loss The FDA approved a new GLP-1 pill from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Pfizer's Experimental GLP-1 Weight Loss

To see the cost of an online Dermatology review or a Mental Health care visit, set up your account now

Adverse effects observed in trials include nausea, vomiting, gallbladder disease, dehydration, and potential pancreatitis

This has driven researchers to explore new approaches

endocrine-abstracts.org Better lipid profiles, reduced visceral adipose tissue: Low testosterone is linked with visceral fat accumulation (which drives metabolic risk)

Such letters may also be required if your insurance company includes weight loss medications in its formulary but denies you coverage

Perhaps other GLP-1-RAs have the similar issue